Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils
- PMID: 6308617
- PMCID: PMC384035
- DOI: 10.1073/pnas.80.14.4349
Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils
Abstract
Chemoattractant N-formylmethionylleucylphenylalanine (fMet-Leu-Phe) in the presence of cytochalasin B stimulates the release of leukotriene B4 (LTB4), superoxide (O2-), and N-acetylglucosaminidase from elicited rat peritoneal and human peripheral neutrophils [PMN (polymorphonuclear leukocytes)]. Prostaglandins E1 and E2 (PGE1 and PGE2) inhibit LTB4 release from PMN in a dose-related manner with an IC50 of 1 X 10(-8) M. This action is associated with increased levels of cyclic AMP. The inhibitory activity of a variety of PGs on LTB4 production by rat peritoneal PMN parallels their affinity for PGE receptors in other tissues. O2- release is also suppressed by low levels of PGE1 and PGE2 in a dose-related manner and this inhibition is enhanced by theophylline. In contrast, lysosomal enzyme release is only minimally affected by physiological levels of PGs. These data are consistent with an action of PGs at the level of the PG receptor on LTB4 and O2- release from the fMet-Leu-Phe-stimulated rat peritoneal PMN. In addition, the fMet-Leu-Phe-induced adherence of PMN to endothelial cells and inhibition of this phenomenon by PGs may now be explained by PG-mediated inhibition of LTB4 formation.
Similar articles
-
Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.Prostaglandins. 1983 Feb;25(2):281-9. doi: 10.1016/0090-6980(83)90110-7. Prostaglandins. 1983. PMID: 6304818
-
Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes.J Exp Med. 1983 Feb 1;157(2):628-41. doi: 10.1084/jem.157.2.628. J Exp Med. 1983. PMID: 6296265 Free PMC article.
-
Release of leukotriene B4 from human neutrophils measured by specific radioimmunoassay.Adv Prostaglandin Thromboxane Leukot Res. 1983;11:215-20. Adv Prostaglandin Thromboxane Leukot Res. 1983. PMID: 6303069 No abstract available.
-
Adenosine. An endogenous inhibitor of arachidonic acid release and leukotriene biosynthesis in human neutrophils.Adv Exp Med Biol. 1999;447:107-15. Adv Exp Med Biol. 1999. PMID: 10086187 Review.
-
Dynamics of human neutrophil receptors for the chemoattractant fmet-leu-phe.Agents Actions Suppl. 1983;12:290-308. doi: 10.1007/978-3-0348-9352-7_17. Agents Actions Suppl. 1983. PMID: 6301232 Review.
Cited by
-
Exogenous arachidonic acid inhibits A23187 stimulated macrophage leukotriene B4 synthesis in vitro.Agents Actions. 1988 Feb;23(1-2):84-5. doi: 10.1007/BF01967197. Agents Actions. 1988. PMID: 2833081 No abstract available.
-
Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils.Proc Natl Acad Sci U S A. 1986 Apr;83(7):2204-8. doi: 10.1073/pnas.83.7.2204. Proc Natl Acad Sci U S A. 1986. PMID: 3457383 Free PMC article.
-
Mesenchymal Stem Cell-Derived Extracellular Vesicles Decrease Lung Injury in Mice.J Immunol. 2019 Oct 1;203(7):1961-1972. doi: 10.4049/jimmunol.1801534. Epub 2019 Aug 26. J Immunol. 2019. PMID: 31451675 Free PMC article.
-
Cyclooxygenase blockade elevates leukotriene E4 production during acute anaphylaxis in sheep.J Exp Med. 1986 Jun 1;163(6):1509-17. doi: 10.1084/jem.163.6.1509. J Exp Med. 1986. PMID: 3011947 Free PMC article.
-
Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach.Br J Pharmacol. 1999 Dec;128(8):1659-66. doi: 10.1038/sj.bjp.0702966. Br J Pharmacol. 1999. PMID: 10588920 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources